The NIH launched a five-year, $10 million research initiative to address the long-term health outcomes stemming from the train derailment on Thursday.

The initiative will examine potential long-term effects of exposure to vinyl chloride and other chemicals released during the 2023 Norfolk Southern train derailment.

The National Institutes of Health said Thursday that it will fund longer-term health studies of the residents of East Palestine, Ohio, after a 2023 train derailment that sent more than a million ...

NIH director Jay Bhattacharya said the move is intended to get answers for the people of East Palestine. AP On Feb. 3, 2023, a 38-car Norfolk Southern freight train transporting hazardous ...

The Trump administration is launching a research initiative into the long-term health outcomes stemming from the 2023 train derailment in East Palestine, Ohio. According to an announceme… ...

Nearly 2½ years after Norfolk Southern’s East Palestine, Ohio, derailment contaminated the area’s soil, water and air, the National Institutes of Health is committing $10 million to study the ...

The National Institutes of Health is undertaking an extended study of the health effects that East Palestine, Ohio, residents have experienced due to the 2023 train derailment there.

The Trump administration announced plans to investigate the long-term health effects of a toxic train derailment in East Palestine, Ohio, as many residents are still reeling from the chemical ...

The National Institutes of Health said Thursday that it will fund longer-term health studies of the residents of East Palestine, Ohio, after a 2023 train derailment that sent more than a million ...

The National Institutes of Health is launching a five-year, $10 million research initiative into the long-term health effects of the February 2023 train derailment in East Palestine, Ohio. In a news ...

“NIH is working to ensure that the people of East Palestine and the surrounding communities are listened to, cared for, and get the answers they deserve,” said a statement from NIH Director ...